Evidence map›Paper›PMID 41182881›Full record

ArticleThe FEBS journal2026

E3 ligase Praja1 mediates ubiquitination and degradation of microtubule-associated protein tau.

Shiho Aoki, Wataru Onodera, Akihiko Takashima, Kotaro Kawasaki, Kazuki Imadegawa, Hikaru Kurahashi, Mizuho Oishi, Toru Asahi, Yoshiyuki Soeda

Abstract read
In one paragraph

Article in The FEBS journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Shiho AokiFaculty of Science and Engineering, Waseda University, Tokyo, Japan.
Wataru OnoderaFaculty of Science and Engineering, Waseda University, Tokyo, Japan.ORCID 0009-0006-0877-2189
Akihiko TakashimaFaculty of Science, Department of Life Science, Laboratory for Alzheimer's Disease, Gakushuin University, Tokyo, Japan.
Kotaro KawasakiFaculty of Science and Engineering, Waseda University, Tokyo, Japan.
Kazuki ImadegawaFaculty of Science and Engineering, Waseda University, Tokyo, Japan.
Hikaru KurahashiFaculty of Science and Engineering, Waseda University, Tokyo, Japan.
Mizuho OishiFaculty of Science and Engineering, Waseda University, Tokyo, Japan.
Toru AsahiFaculty of Science and Engineering, Waseda University, Tokyo, Japan.
Yoshiyuki SoedaFaculty of Science, Department of Life Science, Laboratory for Alzheimer's Disease, Gakushuin University, Tokyo, Japan.

Funding

Agency for Cultural Affairs, Government of Japan JPMXS0440500024Global Consolidated Research Institute for Science, Wisdom, Waseda UniversityOPTORUN Co., Ltd.
6 · The paper itself

Abstract

The RING-H2 type E3 ligase Praja family is composed of E3 ubiquitin-protein ligases Praja1 and Praja2, which promote the degradation of substrates through the ubiquitin-proteasome system. Both paralogs contribute to neuronal maturation and differentiation, indicating a significant role in the nervous system. Aggregation-prone proteins associated with neurodegenerative diseases, including TAR DNA-binding protein 43 (TDP-43) and α-synuclein, are degraded and/or suppressed by Praja1. Furthermore, the expression level of the microtubule-associated protein tau (MAPT) gene, which is frequently mutated in Alzheimer's disease, is regulated by Praja2. Although the Praja family has been shown to recognize various aggregation-prone proteins as substrates, it has not been determined whether tau, a key protein that aggregates in tauopathies, is also recognized by Praja proteins. In this study, we show that Praja1, but not Praja2, recognizes tau as a candidate substrate. We observed that the tau protein level in human neuroblastoma SH-SY5Y cells decreased depending on the E3 ligase activity of Praja1. Furthermore, the in vivo/in vitro ubiquitination assay showed that Praja1 ubiquitinates tau, indicating that it is a target substrate. Next, by combining ancestral sequence reconstruction and mutational analysis, we revealed that the Praja1-tau interaction began just after the duplication of the Praja family in the common ancestor of placentals. Lastly, to test whether this interaction is disrupted under pathological conditions, P301L tau was introduced, resulting in a degradation similar to that of wild-type tau. These results reveal an unidentified mechanism of tau proteostasis by Praja1 and may provide insight into the pathogenesis of neurodegenerative diseases, including tauopathy.

Indexed as

tau ProteinsUbiquitinationUbiquitin-Protein LigasesAlzheimer DiseaseCell Line, TumorHumansProteolysisMAPT protein, humantau ProteinsUbiquitin-Protein LigasesUBR5 protein, humanE3 ubiquitin ligaseGene duplicationMolecular evolutionNeofunctionalizationPraja1Praja familySubstrate specificityTau

Identifiers

PMID41182881
PMCPMC13080228

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.